Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
6(19%)
Results Posted
36%(4 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
13
41%
Ph phase_4
7
22%
Ph phase_1
3
9%
Ph phase_3
2
6%
Ph not_applicable
5
16%
Ph early_phase_1
2
6%

Phase Distribution

5

Early Stage

13

Mid Stage

9

Late Stage

Phase Distribution32 total trials
Early Phase 1First-in-human
2(6.3%)
Phase 1Safety & dosage
3(9.4%)
Phase 2Efficacy & side effects
13(40.6%)
Phase 3Large-scale testing
2(6.3%)
Phase 4Post-market surveillance
7(21.9%)
N/ANon-phased studies
5(15.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

6

trials recruiting

Total Trials

32

all time

Status Distribution
Active(14)
Completed(11)
Terminated(3)
Other(4)

Detailed Status

Completed11
Not yet recruiting8
Recruiting5
unknown4
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
6
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (6.3%)
Phase 13 (9.4%)
Phase 213 (40.6%)
Phase 32 (6.3%)
Phase 47 (21.9%)
N/A5 (15.6%)

Trials by Status

not_yet_recruiting825%
terminated13%
unknown413%
active_not_recruiting13%
completed1134%
recruiting516%
withdrawn26%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT06847321Phase 2

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Recruiting
NCT06954766Phase 2

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

Completed
NCT06601608Phase 2

Efficacy of Locally Delivered Rosemary Extract Gel in Management of Periodontitis

Completed
NCT06799247Phase 3

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Recruiting
NCT07456813Not Applicable

Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period

Not Yet Recruiting
NCT06058520Early Phase 1

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

Recruiting
NCT07303816Phase 4

Statins to Prevent Cancer Associated Blood Clots

Not Yet Recruiting
NCT07190482Phase 1

Treatment of Tinnitus With Olanzapine

Completed
NCT07143864Not Applicable

Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis

Not Yet Recruiting
NCT06527391Phase 2

Choline and Iron Deficiency

Recruiting
NCT07025980Phase 2

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Not Yet Recruiting
NCT03360214Phase 4

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Completed
NCT07007936Phase 2

Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia

Not Yet Recruiting
NCT06901570Phase 4

Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease

Not Yet Recruiting
NCT06809751Phase 2

Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy

Not Yet Recruiting
NCT06793514Phase 1

Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis

Not Yet Recruiting
NCT06717490Not Applicable

Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries

Recruiting
NCT05290558Phase 2

The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial

Active Not Recruiting
NCT05946122Phase 1

Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index

Unknown
NCT05447676Early Phase 1

Effects of 4-AP on Functional SCI Recovery

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
32